Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors
Xiumei Huang(Southwestern Medical Center), Edward A. Motea(Southwestern Medical Center), Zachary Moore(Southwestern Medical Center), Jun Yao(Southwestern Medical Center), Ying Dong(Southwestern Medical Center), Gaurab Chakrabarti(Southwestern Medical Center), Jessica A. Kilgore, Molly A. Silvers(Southwestern Medical Center), Praveen Patidar(Southwestern Medical Center), Agnieszka Cholka(Southwestern Medical Center), Farjana Fattah(Southwestern Medical Center), Yoonjeong Cha(Immuneering (United States)), Glenda G. Anderson, Rebecca Kusko(Immuneering (United States)), Michael Peyton(Texas Oncology), Jingsheng Yan(The University of Texas at Dallas), Xian‐Jin Xie(The University of Texas at Dallas), Venetia Sarode, Noelle S. Williams, John D. Minna(Texas Oncology), Muhammad Shaalan Beg(Texas Oncology), David E. Gerber(Texas Oncology), Erik A. Bey(West Virginia University), David A. Boothman(Southwestern Medical Center)
Cited by 130Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis